Fully vaccinated children are rare: Immunization coverage and seroprevalence in Austrian school children

European Journal of Epidemiology

Volumn 18, Issue 2, 2003, Pages 161-170

  Ringler, Markus ^a,b   Göbel, Georg ^a   Möst, Johannes ^a   Weithaler, Kurt ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Children; Diphtheria; Measles; Mumps; Pertussis; Rubella; Seroprevalence; Vaccination

Indexed keywords

ADOLESCENT; ARTICLE; BLOOD SAMPLING; CHICKENPOX; DIPHTHERIA; EPIDEMIC; FEMALE; HEALTH SURVEY; HUMAN; IMMUNIZATION; MALE; MEASLES; MUMPS; PERTUSSIS; POLIOMYELITIS; PROPHYLAXIS; PUBLIC HEALTH; RUBELLA; SCHOOL CHILD; SEROCONVERSION; SEROLOGY; SEROPREVALENCE; TETANUS PROPHYLAXIS; VACCINATION; VIRUS IMMUNITY;

ADOLESCENT; AUSTRIA; CHICKENPOX; CHILD; DIPHTHERIA; HUMANS; MEASLES; MUMPS; RUBELLA; SEROEPIDEMIOLOGIC STUDIES; VACCINATION; WHOOPING COUGH;

EID: 0344942602     PISSN: 03932990     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023038705835     Document Type: Article

References (54)

1. Peltola H, et al. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program (see comments). N Engl J Med 1994; 331: 1397-1402.
2. Galindo MA, et al. Eradication of measles in Cuba (published erratum appears in Rev Panam Salud Publica 1998 Nov;4(5):345). Rev Panam Salud Publica 1998; 4: 171-177.
3. Osborne K, Weinberg J, Miller E. The European seroepidemiology network. Eurosurveillance Wkly Vol. 2 (4): April 1997.
4. Helwig H, et al. Childhood immunisation in the European Union. Confederation of European Specialists in Paediatrics (CESP). Eur J Pediatr 1998; 157: 676-680.
5. Guerin N, Roure C. Immunization coverage in the European Union. Eurosurveillance Wkly Vol. 2 (1): January 1997.
6. Weithaler K, et al. EPI-Immunization coverage survey in Innsbruck/Austria. Weekly Epidemiological Record No. 25, June 1987.
7. Stronegger WJ, Freidl W. Die Masern-(MMR)-Impfquote bei Haupt- und AHS/Unterstufe-Schulkindern in der Steiermark. Mitteilungen der österreichischen Sanitätsverwaltung 1/1998.
8. Haidinger G, Haschke F, Vutuc C. Vaccination status and sociodemographic variables in Viennese public school students. Soz Praventivmed 1996; 41: 194-199.
9. Strategies to sustain success in childhood immunizations. The National Vaccine Advisory Committee. JAMA 1999; 282: 363-370.
10. Hersh BS, Tambini G, Nogueira AC, Carrasco P, de Quadros CA. Review of regional measles surveillance data in the Americas, 1996-99. Lancet 2000; 355: 1943-1948.
11. Measles outbreak - Netherlands, April 1999-January 2000. MMWR Morb Mortal Wkly Rep 2000; 49: 299-303.
12. Mary M, et al. Six years of public health surveillance of measles in France. Int J Epidemiol 1992; 21: 163-168.
13. Gangarosa EJ, et al. Impact of anti-vaccine movements on pertussis control: The untold story. Lancet 1998; 351: 356-361.
14. Miyamura K, Nishio S, Ito A, Murata R, Kono R. Micro cell culture method for determination of diphtheria toxin and antitoxin titres using VERO cells. I. Studies on factors affecting the toxin and antitoxin titration. J Biol Stand 1974; 2: 189-201.
15. Stohrer-Draxl P, et al. Measles, mumps and rubella: Vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96. Schweiz Rundsch Med Prax 1999; 88: 1069-1077.
16. Bottiger M, Gustavson O, Svensson A. Immunity to tetanus, diphtheria and poliomyelitis in the adult population of Sweden in 1991. Int J Epidemiol 1998; 27: 916-925.
17. Robert Koch Institut. Zur Überprüfung des MMR-Impstatus des Landes Brandenburg 1997/1998. Epidemiologisches Bull 1999; 23: 174-175.
18. Robert Koch Institut. Erhebung von Impfraten zum Zeitpunkt der Einschulung. Epidemiologisches Bull 1999; 23: 171-173.
19. Robert Koch Institut. Impfstatus und Impfempfehlungen in Hauptschulen des Landkreises München. Epidemiologisches Bull 1998; 50: 355-356.
20. Svensson A, Bottiger M, Gustavsson O. Immunity in the Swedish population: Diphtheria, tetanus and poliomyelitis. Int J Epidemiol 1998; 27: 909-915.
21. Bolton P, Holt E, Ross A, Hughart N, Guyer B. Estimating vaccination coverage using parental recall, vaccination cards, and medical records. Public Health 1998; 113: 521-526.
22. Salmaso S, Rota MC, Ciofi Degli Atti ML, Tozzi AE, Kreidl P. Infant immunization coverage in Italy; Estimates by simultaneous EPI cluster surveys of regions. ICONA Study Group. Bull World Health Organ 1999; 77: 843-851.
23. Vitek CR, et al. Risk of diphtheria among schoolchildren in the Russian Federation in relation to time since last vaccination. Lancet 1999; 353: 355-358.
24. Markina SS, Maksimova NM, Vitek CR, Bogatyreva EY, Monisov AA. Diphtheria in the Russian Federation in the 1990s. J Infect Dis 2000; 181 (Suppl 1): S27-S34.
25. Progress toward the global interruption of wild polio-virus type 2 transmission, 1999. MMWR Morb Mortal Wkly Rep 1999; 48: 736-738, 747.
26. Leandro Liberato SV, et al. Child vaccination: The coverage, knowledge and attitudes of the population. A study in a health area. An Esp Pediatr 1996; 44: 464-468.
27. De Spiegelaere M, Dramaix M, Hennart P. Social inequalities and prevention: Vaccination status of adolescents. Rev Epidemiol Sante Publique 1996; 44: 228-236.
28. Mossong J, et al. Modeling the impact of subclinical measles transmission in vaccinated populations with waning immunity. Am J Epidemiol 1999; 150: 1238-1249.
29. Whittle HC, et al. Effect of subclinical infection on maintaining immunity against measles in vaccinated children in West Africa. Lancet 1999; 353: 98-102.
30. Davidkin I, Valle M. Vaccine-induced measles virus antibodies after two doses of combined measles, mumps and rubella vaccine: A 12-year follow-up in two cohorts. Vaccine 1998; 16: 2052-2057.
31. Paunio M, et al. Twice vaccinated recipients are better protected against epidemic measles than are single dose recipients of measles containing vaccine. J Epidemiol Commun Health 1999; 53: 173-178.
32. Galazka A, Kraigher A, Robertson SE. Wide-spread inflammation of the parotid glands (mumps): An underestimated disease. II. Development, use, efficacy and safety of mumps vaccines. Przegl Epidemiol 1998; 52: 401-412.
33. Goh KT. Resurgence of mumps in Singapore caused by the Rubini mumps virus vaccine strain (letter). Lancet 1999; 354: 1355-1356.
34. Cheek JE, Baron R, Atlas H, Wilson DL, Crider RD Jr. Mumps outbreak in a highly vaccinated school population. Evidence for large-scale vaccination failure. Arch Pediatr Adolesc Med 1995; 149: 774-778.
35. Matter HC, Cloetta J, Zimmermann H. Measles, mumps, and rubella: Monitoring in Switzerland through a sentinel network, 1986-94. Sentinella Arbeits gemeinschaft. J Epidemiol Commun Health 1995; 49 (Suppl) 1: 4-8.
36. Condorelli F, et al. Use of a microquantity enzyme immunoassay in a large-scale study of measles, mumps and rubella immunity in Italy. Eur J Clin Microbiol Infect Dis 1998; 17: 49-52.
37. Strohle A, Germann D. Mumps vaccines: virological basis. Soz Praventivmed 1995; 40: 102-109.
38. van Boven M, de Melker HE, Schellekens JF, Kretzschmar M. Waning immunity and sub-clinical infection in an epidemic model: Implications for pertussis in The Netherlands. Math Biosci 2000; 164: 161-182.
39. Hethcote HW. Simulations of pertussis epidemiology in the United States: Effects of adult booster vaccinations. Math Biosci 1999; 158: 47-73.
40. Cherry JD. Epidemiological, clinical, and laboratory aspects of pertussis in adults. Clin Infect Dis 1999; 28 (Suppl 2): S112-S117.
41. van Boven M, de Melker HE, Schellekens JF, Kretzschmar M. Waning immunity and sub-clinical infection in an epidemic model: Implications for pertussis in The Netherlands. Math Biosci 2000; 164: 161-182.
42. Mertens PL, Stals FS, Schellekens JF, Houben AW, Huisman J. An epidemic of pertussis among elderly people in a religious institution in The Netherlands. Eur J Clin Microbiol Infect Dis 1999; 18: 242-247.
43. Garcia-Corbeira P, Dal Re R, Aguilar L, Garcia-de-Lomas J. Seroepidemiology of Bordetella pertussis infections in the Spanish population: A cross-sectional study. Vaccine 2000; 18: 2173-2176.
44. Garcia-Corbeira P, Dal Re R, Garcia-de-Lomas J, Aguilar L. Low prevalence of diphtheria immunity in the Spanish population: Results of a cross-sectional study. Vaccine 1999; 17: 1978-1982.
45. Ballereau F, et al. A multicentre serosurvey on diphtheria immunity in a French population of 1004 subjects. Eur J Epidemiol 1998; 14: 499-503.
46. Hasselhorn HM, Nubling M, Tiller FW, Hofmann F. Factors influencing immunity against diphtheria in adults. Vaccine 1998; 16: 70-75.
47. Coudeville L, Paree F, Lebrun T, Sailly J. The value of varicella vaccination in healthy children: Cost-benefit analysis of the situation in France. Vaccine 1999; 17: 142-151.
48. Lee MS, Lee LL, Chen HY, Wu YC, Horng CB. Post mass-immunization measles outbreak in Taoyuan county, Taiwan: Dynamics of transmission, vaccine effectiveness, and herd immunity. Int J Infect Dis 1999; 3: 64-69.
49. Global measles control and regional elimination, 1998-1999. MMWR Morb Mortal Wkly Rep 1999; 48: 1124-1130.
50. Kessler T. Vaccination status of children in the Vienna area (author's transl). Wien Klin Wochenschr 1978; 90: 835-838.
51. Villalbi JR, et al. Vaccinal coverage at 2 years of age in a socially disadvantaged urban area. Aten Primaria 1992; 9: 154-156.
52. Marks JS, Halpin TJ, Irvin JJ, Johnson DA, Keller JR. Risk factors associated with failure to receive vaccinations. Pediatrics 1979; 64: 304-309.
53. Ziemer B, Blank K, Hennig R, Vaccination status and implementation of recommendations for vaccination with special reference to measles-mumps-rubella vaccination. 1995 program for school entrance. Gesundheitswesen 1998; 60: 297-300.
54. Kunze M. The contribution of social medicine to vaccination in Austria. Wien Med Wochenschr 1998; 148: 191-197.